Back to search

Article

Cell-Free Tumor DNA Dominant Clone Allele Frequency (DCAF) Is Associated With Poor Outcomes In Advanced Biliary Cancers Treated With Platinum-Based Chemotherapy

2021-11-02

Abstract excerpt

<h4>ABSTRACT</h4> <h4>PURPOSE</h4> This investigation sough to evaluate the prognostic value of pre-treatment ctDNA in metastatic biliary tract cancers (BTC) treated with platinum based first-line chemotherapy treatment. <h4>METHODS</h4> We performed a retrospective analysis of 67 patients who underwent ctDNA testing before platinum-based chemotherapy for first-line treatment for metastatic BTC. For analysis we co...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c3c0a15b-a15b-5b96-9e28-752c0a5fcdd6
DOI
10.1101/2021.11.01.21265773
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cell-Free Tumor DNA Dominant Clone Allele Frequency (DCAF) Is Associated With Poor Outcomes In Advanced Biliary Cancers Treated With Platinum-Based ChemotherapyDOI 10.1101/2021.11.01.21265773
Select a neighboring publication to make it the new centre.